ENTITY
WuXi PharmaTech Cayman

WuXi PharmaTech Cayman (WX US)

29
Analysis
Health CareChina
WuXi PharmaTech (Cayman), Inc. provides research services. The Company offers services include researching, analysis, development, and manufacturing of pharmaceutical and biotechnology products.
more
Refresh
01 May 2015 06:34

WuXi's Chairman and Ally Bridge Offer $46/ADS in Going Private Bid

WuXi's Founder, Chairman and CEO, Dr. Ge Li and private equity firm Ally Bridge have made a non-binding offer to take the company private for...

Share
21 Apr 2015 07:53

Increasing Opportunities in Emerging Market CROs

Life sciences R&D spending growth in Asia is outpacing the developed world (US, Canada, and Europe). An article from the January 2, 2014,...

Share
21 Feb 2015 00:02

Opening of E-commerce Channel to Change China's Drug Market

Numerous press outlets report that China’s Food & Drug Administration (CFDA) will release regulations permitting online sales of...

Share
05 Feb 2015 16:01

Introducing Long Term Leaders - Focussed Insights for your Core Holdings

We are pleased to announce the roll out of our latest content vertical: Long Term Leaders. Under this category,  we have identified companies that...

Logo
309 Views
Share
x